Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Maruta

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Bone Marrow Transplantation|March 30, 2001
Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fractionK Fujimaki, A Maruta, M Yoshida, et al.
Bone Marrow Transplantation|September 3, 2008
Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCTK Oda, C Nakaseko, S Ozawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1996
[Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy]M Hattori, S Motomura, N Tomita, et al.
International Journal of Laboratory Hematology|July 4, 2009
Myeloablative hematopoietic stem cell transplantation for myelodysplastic syndrome in patients younger than 55 years: impact of comorbidity and disease burden on the long-term outcomeH Kanamori, M Enaka, S Ito, et al.
Leukemia & Lymphoma|June 25, 1998
Residual leukemic cell counts in the bone marrow at the end point of intensive induction therapy may be a prognostic factor for acute myeloblastic leukemia in adultsS Fujisawa, A Maruta, S Motomura, et al.
Bone Marrow Transplantation|October 24, 2000
Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcomeS Shiobara, S Nakao, M Ueda, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|March 22, 2001
Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: indications and dose escalationS Shiobara, S Nakao, M Ueda, et al.
American Journal of Hematology|May 18, 2000
The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantationK Ohashi, J Tanabe, R Watanabe, et al.
International Journal of Hematology|April 4, 2000
Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factorsK Takeyama, M Seto, N Uike, et al.
Leukemia|April 30, 2010
Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemiaH Nakasone, Y Kanda, H Takasaki, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Bone Marrow Transplantation|March 30, 2001
Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fractionK Fujimaki, A Maruta, M Yoshida, et al.
Bone Marrow Transplantation|September 3, 2008
Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCTK Oda, C Nakaseko, S Ozawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1996
[Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy]M Hattori, S Motomura, N Tomita, et al.
International Journal of Laboratory Hematology|July 4, 2009
Myeloablative hematopoietic stem cell transplantation for myelodysplastic syndrome in patients younger than 55 years: impact of comorbidity and disease burden on the long-term outcomeH Kanamori, M Enaka, S Ito, et al.
Leukemia & Lymphoma|June 25, 1998
Residual leukemic cell counts in the bone marrow at the end point of intensive induction therapy may be a prognostic factor for acute myeloblastic leukemia in adultsS Fujisawa, A Maruta, S Motomura, et al.
Bone Marrow Transplantation|October 24, 2000
Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcomeS Shiobara, S Nakao, M Ueda, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|March 22, 2001
Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: indications and dose escalationS Shiobara, S Nakao, M Ueda, et al.
American Journal of Hematology|May 18, 2000
The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantationK Ohashi, J Tanabe, R Watanabe, et al.
International Journal of Hematology|April 4, 2000
Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factorsK Takeyama, M Seto, N Uike, et al.
Leukemia|April 30, 2010
Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemiaH Nakasone, Y Kanda, H Takasaki, et al.
Pageof 10